• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学实验的最佳采样时间。

Optimal sampling times for pharmacokinetic experiments.

作者信息

D'Argenio D Z

出版信息

J Pharmacokinet Biopharm. 1981 Dec;9(6):739-56. doi: 10.1007/BF01070904.

DOI:10.1007/BF01070904
PMID:7341758
Abstract

A sequential estimation procedure is presented which uses optimal sampling times to estimate the parameters of a model from data obtained from a group of subjects. This optimal sampling sequential estimation procedure utilizes parameter estimates from previous subjects in the group to determine the optimal sampling times for the next subject. Parameter estimates obtained from the optimal sampling procedure are compared to those obtained from a conventional sampling scheme by using Monte Carlo simulations which include noise terms for both assay error and intersubject variability. The results of these numerical experiments, for the two examples considered here, show that the parameter estimates obtained from data collected at optimal sampling times have significantly less variability than those generated using the conventional sampling procedure. We conclude that optimal sampling and preexperiment simulation may be useful tools for designing informative pharmacokinetic experiments.

摘要

本文提出了一种序贯估计程序,该程序使用最优采样时间从一组受试者获得的数据中估计模型参数。这种最优采样序贯估计程序利用组中先前受试者的参数估计来确定下一个受试者的最优采样时间。通过蒙特卡罗模拟将从最优采样程序获得的参数估计与从传统采样方案获得的参数估计进行比较,蒙特卡罗模拟包括分析误差和受试者间变异性的噪声项。对于这里考虑的两个例子,这些数值实验的结果表明,在最优采样时间收集的数据所获得的参数估计的变异性明显小于使用传统采样程序产生的变异性。我们得出结论,最优采样和实验前模拟可能是设计信息丰富的药代动力学实验的有用工具。

相似文献

1
Optimal sampling times for pharmacokinetic experiments.药代动力学实验的最佳采样时间。
J Pharmacokinet Biopharm. 1981 Dec;9(6):739-56. doi: 10.1007/BF01070904.
2
Sampling strategies for noncompartmental estimation of mean residence time.
J Pharmacokinet Biopharm. 1983 Aug;11(4):435-46. doi: 10.1007/BF01058960.
3
A sequential Monte Carlo approach to derive sampling times and windows for population pharmacokinetic studies.一种用于推导群体药代动力学研究采样时间和窗口的序贯蒙特卡罗方法。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):519-26. doi: 10.1007/s10928-012-9265-1. Epub 2012 Jul 31.
4
A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.一种用于确定非线性混合效应模型采样窗口的通用方法及其在群体药代动力学研究中的应用。
Pharm Stat. 2012 Jul-Aug;11(4):325-33. doi: 10.1002/pst.1509. Epub 2012 Mar 12.
5
A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.一个关于结构模型参数估计对患者报告给药时间误差敏感性的药代动力学案例研究。
J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):627-37. doi: 10.1007/s10928-015-9428-y. Epub 2015 Jul 26.
6
[Value of the theory of the optimal sampling scheme for bioequivalence studies].[生物等效性研究中最优抽样方案理论的价值]
Therapie. 1993 Jan-Feb;48(1):7-13.
7
Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.在序贯采样设计中进行药代动力学参数的非隔室估计。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):479-94. doi: 10.1007/s10928-009-9133-9. Epub 2009 Oct 22.
8
Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation.稳态预测对参数估计误差的灵敏度的解析近似值。
J Pharmacokinet Biopharm. 1982 Oct;10(5):559-74. doi: 10.1007/BF01059038.
9
Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.哌拉西林/他唑巴坦在新生儿和小婴儿群体药代动力学研究中的目标达成分析及最优抽样设计
Eur J Clin Pharmacol. 2016 Dec;72(12):1479-1488. doi: 10.1007/s00228-016-2131-0. Epub 2016 Sep 19.
10
Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics.药代动力学中用于稳健优化采样时间的ED、EID和API标准的比较。
J Pharmacokinet Biopharm. 1997 Aug;25(4):515-37. doi: 10.1023/a:1025701327672.

引用本文的文献

1
Developing a PK-PD model for propofol in exhaled air and the BIS following fospropofol disodium in beagles.建立比格犬静脉注射磷丙泊酚二钠后呼出气中丙泊酚及脑电双频指数(BIS)的药代动力学-药效学模型。
BMC Vet Res. 2025 Feb 28;21(1):124. doi: 10.1186/s12917-025-04570-w.
2
Real-world pharmacokinetics of trametinib in pediatric low-grade glioma.曲美替尼在儿童低级别胶质瘤中的真实世界药代动力学
Cancer Chemother Pharmacol. 2025 Feb 25;95(1):35. doi: 10.1007/s00280-025-04761-0.
3
Confirming the Suitability of a Gentamicin Dosing Strategy in Neonates Using the Population Pharmacokinetic Approach with Truncated Sampling Duration.

本文引用的文献

1
Investigation of the effect of data error in the analysis of biological tracer data from three compartment systems.三室系统生物示踪剂数据分析中数据误差影响的研究
J Theor Biol. 1969 May;23(2):218-31. doi: 10.1016/0022-5193(69)90038-1.
2
Disposition kinetics of lidocaine in normal subjects.
Ann N Y Acad Sci. 1971 Jul 6;179:383-98. doi: 10.1111/j.1749-6632.1971.tb46915.x.
3
Problems associated with analysis of pharmacokinetic models.与药代动力学模型分析相关的问题。
J Pharm Sci. 1971 Jun;60(6):882-5. doi: 10.1002/jps.2600600616.
采用截短采样时长的群体药代动力学方法确定庆大霉素给药策略在新生儿中的适用性。
Children (Basel). 2024 Jul 26;11(8):898. doi: 10.3390/children11080898.
4
Bayesian optimization of tacrolimus exposure in stable kidney transplant patients.稳定期肾移植患者他克莫司暴露的贝叶斯优化。
Pharmacotherapy. 2023 Oct;43(10):1032-1042. doi: 10.1002/phar.2848. Epub 2023 Jul 23.
5
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling.基于细胞动力学/动态模型优化 CAR-T 细胞暴露的自体 CAR-T 细胞疗法的模型指导药物研发策略。
CPT Pharmacometrics Syst Pharmacol. 2023 Nov;12(11):1577-1590. doi: 10.1002/psp4.13011. Epub 2023 Jul 28.
6
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children.儿童体内的艾沙康唑药代动力学与药效学
Pharmaceutics. 2022 Dec 26;15(1):75. doi: 10.3390/pharmaceutics15010075.
7
Application of Machine Learning Classification to Improve the Performance of Vancomycin Therapeutic Drug Monitoring.应用机器学习分类法提高万古霉素治疗药物监测的性能
Pharmaceutics. 2022 May 9;14(5):1023. doi: 10.3390/pharmaceutics14051023.
8
Development and Validation of Open-Source R Package HMCtdm for Therapeutic Drug Monitoring.用于治疗药物监测的开源R包HMCtdm的开发与验证
Pharmaceuticals (Basel). 2022 Jan 21;15(2):127. doi: 10.3390/ph15020127.
9
Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen.六项临床研究的综合数据分析指向他莫昔芬的模型指导精准给药。
Front Pharmacol. 2020 Mar 31;11:283. doi: 10.3389/fphar.2020.00283. eCollection 2020.
10
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.癌症患者中伊立替康(CPT-11)及其活性代谢物(SN-38)的最佳采样策略。
AAPS J. 2020 Mar 17;22(3):59. doi: 10.1208/s12248-020-0429-4.
4
Use of statistical methods in evaluation of in vivo performance of dosage forms.统计学方法在剂型体内性能评价中的应用。
J Pharm Sci. 1973 Oct;62(10):1579-89. doi: 10.1002/jps.2600621002.
5
Statistical estimations in pharmacokinetics.药物动力学中的统计学估计
J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.
6
Blood ethanol concentrations during and following constant-rate intravenous infusion of alcohol.酒精恒速静脉输注期间及之后的血液乙醇浓度
Clin Pharmacol Ther. 1976 Feb;19(2):213-23. doi: 10.1002/cpt1976192213.
7
Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.根据常规临床数据估算药代动力学参数的群体特征。
J Pharmacokinet Biopharm. 1977 Oct;5(5):445-79. doi: 10.1007/BF01061728.
8
Pharmacokinetics--uses and abuses.药代动力学——应用与滥用
Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):241-8. doi: 10.1007/BF00567122.
9
A program package for simulation and parameter estimation in pharmacokinetic systems.一个用于药代动力学系统模拟和参数估计的程序包。
Comput Programs Biomed. 1979 Mar;9(2):115-34. doi: 10.1016/0010-468x(79)90025-4.
10
A priori lithium dosage regimen using population characteristics of pharmacokinetic parameters.利用药代动力学参数的人群特征制定的先验锂剂量方案。
J Pharmacokinet Biopharm. 1979 Dec;7(6):579-628. doi: 10.1007/BF01061210.